Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederglobenewswire.com
Novartis International AG
Get the latest updates from Novartis International AG directly as they happen.
Follow now 51 followers
Latest posts
Last updated about 19 hours ago
Novartis breaks ground on flagship manufacturing hub in North Carolina
about 19 hours ago
East Hanover, December 12, 2025 – Novartis, a leading global innovative medicines...
Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses
4 days ago
Basel, December 9, 2025 – Novartis today announced positive results from VAYHIT2...
1 in 4 metastatic breast cancer patients treated with Novartis Kisqali® remain progression-free beyond 4 years
4 days ago
Basel, December 9, 2025 – Novartis today announced results showing that one...
Novartis data underscore pioneering scientific innovation in hematology and oncology at ASH and SABCS
18 days ago
Basel, November 25, 2025 – Novartis will present data from over 70...
Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS
18 days ago
Basel, November 25, 2025 – Novartis will present data from over 70...
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
18 days ago
Ad hoc announcement pursuant to Art. 53 LR
Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by 30+ potential high-value pipeline assets
23 days ago
Ad hoc announcement pursuant to Art. 53 LR
Novartis announces plans to build flagship manufacturing hub in North Carolina
24 days ago
Basel, November 19, 2025 – Novartis, a leading global innovative medicines company...
Novartis announces plans to build flagship manufacturing hub in North Carolina
24 days ago
East Hanover, November 19, 2025 – Novartis, a leading global innovative medicines...
Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance
about 1 month ago
Basel, November 12, 2025 – Novartis today announced positive results from KALUMA...
Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan
about 1 month ago
Basel, November 10, 2025 – Novartis, a leading global innovative medicines company...
New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline
about 1 month ago
Basel, November 4, 2025 – Novartis will present new data from 33...